Dr. Teng is Director of Gynecologic Oncology and Associate Professor of Obstetrics and Gynecology, Stanford University School of Medicine.  OncologySTAT: In your view, which developments in gynecologic oncology research that occurred in 2010 could have the most significant impact on oncology?Dr. Teng: The two biggest challenges in ovarian cancer treatment, in my view, are the need for early diagnosis and the lack of progress for treatment of drug-resistant disease. In terms of early diagnosis, the...